Results: Patients with mild, moderate, and severe symptoms who received curcumin/piperine treatment showed early symptomatic recovery (fever, cough, sore throat, and breathlessness), less deterioration, fewer red flag signs, better ability to maintain oxygen saturation above 94% on room air, and better clinical outcomes compared to patients of the control group. Furthermore, curcumin/piperine treatment appeared to reduce the duration of hospitalization in patients with moderate to severe symptoms, and fewer deaths were observed in the curcumin/piperine treatment group.
Conservative. Idaho. Software engineer. Historian. Trying to prevent Idiocracy from becoming a documentary.
Email complaints/requests about copyright infringement to clayton @ claytoncramer.com. Reminder: the last copyright troll that bothered me went bankrupt.
"And we know that all things work together for good to them that love God, to them who are the called according to his purpose." -- Rom. 8:28Friday, December 17, 2021
Frontiers in Pharmacology
Peer reviewed randomized clinical trial:
Subscribe to:
Post Comments (Atom)
Makes sense.
ReplyDeleteCurcumin is anti-inflamatory:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572027/
And there's plenty of evidence that SARS-COV-2 causes inflamation, including in fat cells.
Well, that explains the four different Turmeric delivery systems I've seen in the vitamins and minerals section of Costco.
ReplyDelete